Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06965426 · ClinicalTrials.gov registry record · NA
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
A NA study of Macular Degenerative Disease, sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06965426: Recruiting NA study of Macular Degenerative Disease, sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,.
NCT06965426 is a NA study of Macular Degenerative Disease that is actively recruiting participants, run by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06965426, a NA study of Macular Degenerative Disease, is actively recruiting participants, sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Primary Outcome
Change in skin carotenoid concentration over supplementation vs. placebo exposure durations.
Conditions Studied
Interventions
- OTHER Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Study Locations (1)
Missouri
- Vision Source - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06965426 shows while recruiting
NCT06965426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Macular Degenerative Disease appearing as the primary indexed condition, and to 1 intervention - of which Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation is the first listed.
NCT06965426 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06965426 about?
NCT06965426 is a clinical study titled "Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study". To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
What is the current status of trial NCT06965426?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-06-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06965426 study?
This clinical trial studies the following conditions: Macular Degenerative Disease.
What interventions are being tested in trial NCT06965426?
The interventions under investigation include: Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation (OTHER).
Who is sponsoring clinical trial NCT06965426?
This trial is sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06965426 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06965426's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI